Blossom Therapy Center Llc | |
7411 Riggs Rd Ste 308, Adelphi, MD 20783-4246 | |
(443) 839-2268 | |
Not Available |
Full Name | Blossom Therapy Center Llc |
---|---|
Type | Facility |
Speciality | Speech-language Pathologist |
Location | 7411 Riggs Rd Ste 308, Adelphi, Maryland |
Accepts Medicare Assignments | Does not participate in Medicare Program. The facility may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1003679507 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
225X00000X | Occupational Therapist | (* (Not Available)) | Secondary |
235Z00000X | Speech-language Pathologist | (* (Not Available)) | Primary |
Mailing Address | Practice Location Address |
---|---|
Blossom Therapy Center Llc 6612 Weaver Ct, Laurel, MD 20707-2797 Ph: (443) 839-2268 | Blossom Therapy Center Llc 7411 Riggs Rd Ste 308, Adelphi, MD 20783-4246 Ph: (443) 839-2268 |
News Archive
Research into human fossils dating back to approximately two million years ago reveals that the hearing pattern resembles chimpanzees, but with some slight differences in the direction of humans.
An ethnic population at high risk for Type 2 diabetes achieved significant control of the disease through participation in community-based health programs, demonstrating that active intervention and culturally-sensitive education can reverse the course of certain illnesses.
Using a combination of polymers that respond to temperature, a research team at the University of Utah has developed a multifunctional nanoparticle that can image tumors using ultrasound and simultaneously deliver cell-damaging energy and anticancer drugs to those tumors. In addition, these nanoparticles appear to act specifically on tumors and not on healthy tissue.
Also in Medicaid news: In Alabama, an examination of pharmacy receipts leads to reduced costs. But in Texas, some hospital systems are bracing for the impact of Medicaid cuts currently under discussion in the debt-ceiling talks.
An international study led by the University of Sydney and published in the Annals of Neurology has the potential to improve the design of clinical trials for the treatment of Charcot-Marie-Tooth disease, a disorder which affects the peripheral nervous system.
› Verified 1 days ago